Alain T. Sane

Montreal, QC H3T1C5, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

Therapeutic Potential of Cranberry Proanthocyanidins in Addressing the Pathophysiology of Metabolic Syndrome: A Scrutiny of Select Mechanisms of Action.

Therapeutic Potential of Cranberry Proanthocyanidins in Addressing the Pathophysiology of Metabolic Syndrome: A Scrutiny of Select Mechanisms of Action.

Journal: Antioxidants (Basel, Switzerland)
Published: January 10, 2025

Unraveling Chylomicron Retention Disease Enhances Insight into SAR1B GTPase Functions and Mechanisms of Actions, While Shedding Light of Intracellular Chylomicron Trafficking.

Unraveling Chylomicron Retention Disease Enhances Insight into SAR1B GTPase Functions and Mechanisms of Actions, While Shedding Light of Intracellular Chylomicron Trafficking.

Journal: Biomedicines
Published: May 22, 2024

Glycomacropeptide as an Efficient Agent to Fight Pathophysiological Mechanisms of Metabolic Syndrome.

Glycomacropeptide as an Efficient Agent to Fight Pathophysiological Mechanisms of Metabolic Syndrome.

Journal: Nutrients
Published: January 29, 2024

High-fat diet reveals the impact of Sar1b defects on lipid and lipoprotein profile and cholesterol metabolism.

High-fat diet reveals the impact of Sar1b defects on lipid and lipoprotein profile and cholesterol metabolism.

Journal: Journal of lipid research
Published: May 05, 2023

Cranberry Proanthocyanidins as a Therapeutic Strategy to Curb Metabolic Syndrome and Fatty Liver-Associated Disorders.

Cranberry Proanthocyanidins as a Therapeutic Strategy to Curb Metabolic Syndrome and Fatty Liver-Associated Disorders.

Journal: Antioxidants (Basel, Switzerland)
Published: November 04, 2022

Glycomacropeptide for Management of Insulin Resistance and Liver Metabolic Perturbations.

Glycomacropeptide for Management of Insulin Resistance and Liver Metabolic Perturbations.

Journal: Biomedicines
Published: August 06, 2021

Sar1b mutant mice recapitulate gastrointestinal abnormalities associated with chylomicron retention disease.

Sar1b mutant mice recapitulate gastrointestinal abnormalities associated with chylomicron retention disease.

Journal: Journal of lipid research
Published: February 25, 2021

Phospholipase D as a Potential Modulator of Metabolic Syndrome: Impact of Functional Foods.

Phospholipase D as a Potential Modulator of Metabolic Syndrome: Impact of Functional Foods.

Journal: Antioxidants & redox signaling
Published: June 27, 2020

Glycomacropeptide Prevents Iron/Ascorbate-Induced Oxidative Stress, Inflammation and Insulin Sensitivity with an Impact on Lipoprotein Production in Intestinal Caco-2/15 Cells.

Glycomacropeptide Prevents Iron/Ascorbate-Induced Oxidative Stress, Inflammation and Insulin Sensitivity with an Impact on Lipoprotein Production in Intestinal Caco-2/15 Cells.

Journal: Nutrients
Published: March 26, 2020

SAR1B GTPase is necessary to protect intestinal cells from disorders of lipid homeostasis, oxidative stress, and inflammation.

SAR1B GTPase is necessary to protect intestinal cells from disorders of lipid homeostasis, oxidative stress, and inflammation.

Journal: Journal of lipid research
Published: May 06, 2019

Acylated Ghrelin and The Regulation of Lipid Metabolism in The Intestine.

Acylated Ghrelin and The Regulation of Lipid Metabolism in The Intestine.

Journal: Scientific reports
Published: January 04, 2019

CFTR Deletion Confers Mitochondrial Dysfunction and Disrupts Lipid Homeostasis in Intestinal Epithelial Cells.

CFTR Deletion Confers Mitochondrial Dysfunction and Disrupts Lipid Homeostasis in Intestinal Epithelial Cells.

Journal: Nutrients
Published: May 29, 2018
Showing 1-12 of 20

Last Updated: 09/26/2026